Behind the Antibody Cocktail Rush, Mega Profits for Private Hospitals and Pharma Companies
| |

Behind the Antibody Cocktail Rush, Mega Profits for Private Hospitals and Pharma Companies

With a surge in Covid-19 cases, private hospitals in Mumbai are seeing a rise in admissions for the monoclonal antibody treatment, despite many patients not needing it. The hospitals are making large, easy profits on the treatment.